Key result
T2D duration over 10 years is linked to higher BNP in asymptomatic nonhypertensive nonischemic patients.
Why the study?
Noninvasive assessment of left ventricular functions in asymptomatic nonhypertensive nonischemic type 2 diabetics and correlation with BNP levels for early management before overt heart failure were needed.
Does tissue Doppler imaging and BNP measurement detect subclinical left ventricular dysfunction in asymptomatic nonhypertensive nonischemic type 2 diabetic patients?
Cross-Sectional (n=55)
Does tissue Doppler imaging and BNP measurement detect subclinical left ventricular dysfunction in asymptomatic nonhypertensive nonischemic type 2 diabetic patients?
p-value: p=0.008
In asymptomatic type 2 diabetics, TDI frequently detects subclinical diastolic dysfunction, while elevated BNP correlates with longer diabetes duration and systolic dysfunction rather than diastolic dysfunction severity.
Should not yet change practice; leaves open BNP's additive value to TDI for subclinical dysfunction screening.
Cardiovascular diseases account for about 65% of diabetes-related mortality. Noninvasive assessment of left ventricular functions in asymptomatic nonhypertensive nonischemic type 2 diabetics using echo heart and tissue Doppler imaging (TDI) for detecting structural and functional cardiac abnormalities, and correlating them with levels of Brain natriuretic peptide (BNP) for early planning of management before passing into overt heart failure (HF) were the objectives of this study. We studied 55 patients with type 2 diabetes and classified them into two groups: 26 patients with less than 10 years diabetes duration and 29 patients with more than 10 years duration. Full history, fasting blood glucose, postprandial blood glucose, glycated hemoglobin, creatinine, lipid profile, BNP, ECG, conventional echo, and TDI were performed for all patients. In all, 45 (80%) patients out of 55 patients have diastolic dysfunction, classified as 15 (27%) with type 1 diastolic dysfunction, 26 (47%) with type 2 pseudonormal diastolic dysfunction, and four (7%) patients with type 3 diastolic dysfunction. Systolic dysfunction (ejection fraction <55) was present in nine (16%) patients despite absent HF. BNP was significantly high in patients with longer diabetes duration ( P =0.008). There was a statistically significant difference in the BNP level between those with diminished systolic function and those with normal systolic function, P =0.001; yet no statistically significant difference was found between BNP and different groups of diastolic dysfunction ( P =0.7). Diabetic cardiomyopathy is an important diabetes complication. It varies from subclinical ventricular dysfunction to overt HF. Echocardiography is the standard diagnostic tool for diabetic cardiomyopathy. TDI can be used to quantitatively assess global, regional, systolic, and diastolic myocardial functions. Plasma BNP can be a prognostic rather than diagnostic test.
No takes yet. Share an insight, caveat, or question.
Zakria et al. (2017) conducted a cross-sectional in Type 2 diabetes mellitus (n=55). Diabetes duration >10 years vs. Diabetes duration <10 years was evaluated on BNP level (p=0.008). Longer diabetes duration (>10 years) was associated with significantly higher BNP levels (P=0.008) in asymptomatic nonhypertensive nonischemic patients with type 2 diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: